Sam Chun Dang Pharm. Co. Ltd (000250) — Cash Flow-to-Debt Ratio
Sam Chun Dang Pharm. Co. Ltd (000250) has a Cash Flow-to-Debt Ratio of 0.07x as of June 2026, meaning its operating cash flow of ₩12.04 Billion could theoretically repay 0% of its total liabilities (₩174.61 Billion) in one year. See 000250 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sam Chun Dang Pharm. Co. Ltd Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Sam Chun Dang Pharm. Co. Ltd across 14 annual periods. For the full cash flow conversion analysis, see Sam Chun Dang Pharm. Co. Ltd (000250) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Sam Chun Dang Pharm. Co. Ltd (2012–2025)
Year-by-year debt coverage analysis for Sam Chun Dang Pharm. Co. Ltd. Check Sam Chun Dang Pharm. Co. Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | ₩9.79 Billion | ₩197.64 Billion | ▼ -42.3% |
| 2024 | 0.09x | ₩21.77 Billion | ₩253.67 Billion | ▼ -59.9% |
| 2023 | 0.21x | ₩23.43 Billion | ₩109.56 Billion | ▲ +220.5% |
| 2022 | 0.07x | ₩13.28 Billion | ₩199.05 Billion | ▲ +248.8% |
| 2021 | -0.04x | ₩-7.71 Billion | ₩171.90 Billion | ▼ -280.0% |
| 2020 | 0.02x | ₩3.25 Billion | ₩130.45 Billion | ▼ -89.2% |
| 2019 | 0.23x | ₩30.60 Billion | ₩132.28 Billion | ▲ +4.1% |
| 2018 | 0.22x | ₩25.03 Billion | ₩112.64 Billion | ▼ -24.3% |
| 2017 | 0.29x | ₩26.09 Billion | ₩88.80 Billion | ▲ +32.2% |
| 2016 | 0.22x | ₩17.76 Billion | ₩79.95 Billion | ▼ -10.4% |
| 2015 | 0.25x | ₩17.34 Billion | ₩69.94 Billion | ▼ -58.4% |
| 2014 | 0.60x | ₩19.55 Billion | ₩32.81 Billion | ▲ +35.1% |
| 2013 | 0.44x | ₩15.94 Billion | ₩36.15 Billion | ▲ +875.6% |
| 2012 | 0.05x | ₩1.60 Billion | ₩35.44 Billion | — |